Findings show imaging biomarkers predict chemotherapy toxicity in patients with diffuse large B-cell lymphoma, suggesting improved patient management.
Lower baseline SM volume and its reductions during treatment are associated with an increased risk of grade 3/4 toxicity, particularly in overweight or obese patients. Body composition measurements serve as effective imaging biomarkers.
No takes yet. Share an insight, caveat, or question.
An et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: